322 related articles for article (PubMed ID: 10982414)
1. Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase.
Cooley MA; Broome JM; Ohngemach C; Romer LH; Schaller MD
Mol Biol Cell; 2000 Sep; 11(9):3247-63. PubMed ID: 10982414
[TBL] [Abstract][Full Text] [Related]
2. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.
Brown MC; Perrotta JA; Turner CE
J Cell Biol; 1996 Nov; 135(4):1109-23. PubMed ID: 8922390
[TBL] [Abstract][Full Text] [Related]
3. Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases.
Schaller MD; Hildebrand JD; Parsons JT
Mol Biol Cell; 1999 Oct; 10(10):3489-505. PubMed ID: 10512882
[TBL] [Abstract][Full Text] [Related]
4. GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes.
Heidkamp MC; Bayer AL; Kalina JA; Eble DM; Samarel AM
Circ Res; 2002 Jun; 90(12):1282-9. PubMed ID: 12089066
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation.
Shen Y; Schaller MD
Mol Biol Cell; 1999 Aug; 10(8):2507-18. PubMed ID: 10436008
[TBL] [Abstract][Full Text] [Related]
6. The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin.
Hayashi I; Vuori K; Liddington RC
Nat Struct Biol; 2002 Feb; 9(2):101-6. PubMed ID: 11799401
[TBL] [Abstract][Full Text] [Related]
7. NMR solution structure of the focal adhesion targeting domain of focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site binding model.
Gao G; Prutzman KC; King ML; Scheswohl DM; DeRose EF; London RE; Schaller MD; Campbell SL
J Biol Chem; 2004 Feb; 279(9):8441-51. PubMed ID: 14662767
[TBL] [Abstract][Full Text] [Related]
8. Human caco-2 motility redistributes FAK and paxillin and activates p38 MAPK in a matrix-dependent manner.
Yu CF; Sanders MA; Basson MD
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G952-66. PubMed ID: 10859226
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase.
Bellis SL; Miller JT; Turner CE
J Biol Chem; 1995 Jul; 270(29):17437-41. PubMed ID: 7615549
[TBL] [Abstract][Full Text] [Related]
10. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase.
Hildebrand JD; Schaller MD; Parsons JT
Mol Biol Cell; 1995 Jun; 6(6):637-47. PubMed ID: 7579684
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an activated mutant of focal adhesion kinase: 'SuperFAK'.
Gabarra-Niecko V; Keely PJ; Schaller MD
Biochem J; 2002 Aug; 365(Pt 3):591-603. PubMed ID: 11988069
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association.
Liu ZX; Yu CF; Nickel C; Thomas S; Cantley LG
J Biol Chem; 2002 Mar; 277(12):10452-8. PubMed ID: 11784715
[TBL] [Abstract][Full Text] [Related]
13. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury.
van de Water B; Houtepen F; Huigsloot M; Tijdens IB
J Biol Chem; 2001 Sep; 276(39):36183-93. PubMed ID: 11447217
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation.
Richardson A; Malik RK; Hildebrand JD; Parsons JT
Mol Cell Biol; 1997 Dec; 17(12):6906-14. PubMed ID: 9372922
[TBL] [Abstract][Full Text] [Related]
15. Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin.
Bellis SL; Perrotta JA; Curtis MS; Turner CE
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):375-81. PubMed ID: 9230116
[TBL] [Abstract][Full Text] [Related]
16. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK.
Tachibana K; Sato T; D'Avirro N; Morimoto C
J Exp Med; 1995 Oct; 182(4):1089-99. PubMed ID: 7561682
[TBL] [Abstract][Full Text] [Related]
17. Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region.
Turner CE; Miller JT
J Cell Sci; 1994 Jun; 107 ( Pt 6)():1583-91. PubMed ID: 7525621
[TBL] [Abstract][Full Text] [Related]
18. An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells.
Sundberg LJ; Galante LM; Bill HM; Mack CP; Taylor JM
J Biol Chem; 2003 Aug; 278(32):29783-91. PubMed ID: 12782622
[TBL] [Abstract][Full Text] [Related]
19. Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase.
Wade R; Bohl J; Vande Pol S
Oncogene; 2002 Jan; 21(1):96-107. PubMed ID: 11791180
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy.
Kovacic-Milivojević B; Roediger F; Almeida EA; Damsky CH; Gardner DG; Ilić D
Mol Biol Cell; 2001 Aug; 12(8):2290-307. PubMed ID: 11514617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
